The company said April 21 that its diluted earnings per share were $2.92, down 15.6 percent from 2021. Excluding COVID-19 testing, the company pulled in $2.01 billion, up more than six percent year-over-year.
COVID-19 testing revenues fell from $828 million in the first quarter of 2021 to $599 million in the first quarter of 2022, a drop of 27.6 percent.
Quest now expects its full year 2022 net revenue to land between $9.2 billion and $9.5 billion, with a per-share earning between $7.88 and $8.38.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
